VIR - Vir Biotechnology GAAP EPS of -$0.76 misses by $0.42 revenue of $49.4M misses by $84.84M February, 23 2023 04:07 PM Vir Biotechnology Inc. Vir Biotechnology press release ( NASDAQ: VIR ): Q4 GAAP EPS of -$0.76 misses by $0.42 . Revenue of $49.4M (-93.9% Y/Y) misses by $84.84M . For further details see: Vir Biotechnology GAAP EPS of -$0.76 misses by $0.42, revenue of $49.4M misses by $84.84M